SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q3 EPS of ($0.30), $0.07 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $19.5 million versus the consensus estimate of $18.3 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2025 revenue of $75-77 million, versus the consensus of $74.52 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.